Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camille Tlemsani

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Bulletin Du Cancer|January 7, 2024
[The French National College of Oncology Teachers (CNEC): Missions, organization, and projects]Florence Huguet, Camille Tlemsani, Jean-Yves Pierga, et al.
STAR Protocols|September 26, 2025
Protocol to set up the CellMinerCDB pharmacogenomics analysis web application with custom cell line dataFathi Elloumi, Camille Tlemsani, Christine M Heske, et al.
Iscience|June 13, 2024
Sarcoma_CellminerCDB: A tool to interrogate the genomic and functional characteristics of a comprehensive collection of sarcoma cell linesCamille Tlemsani, Christine M Heske, Fathi Elloumi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 2016
Acute neurovascular events in cancer patients receiving anti-vascular endothelial growth factor agents: Clinical experience in Paris University HospitalsCamille Tlemsani, Olivier Mir, Dimitri Psimaras, et al.
Clinical Medicine (London, England)|August 3, 2021
Impact of the COVID-19 pandemic on the management of cancer patients: the experience of the cancer outpatients department of a university hospital in ParisCamille Tlemsani, Jennifer Arrondeau, Sixtine De Percin, et al.
Investigational New Drugs|November 1, 2016
Erlotinib pharmacokinetics: a critical parameter influencing acute toxicity in elderly patients over 75 years-oldFrederic Bigot, Pascaline Boudou-Rouquette, Jennifer Arrondeau, et al.
International Journal of Molecular Sciences|January 21, 2023
Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment OptionsCamille Tlemsani, Frédérique Larousserie, Sixtine De Percin, et al.
The American Journal of the Medical Sciences|July 26, 2018
BRCA2 Loss-of-Function and High Sensitivity to Cisplatin-Based Chemotherapy in a Patient With a Pleomorphic Soft Tissue Sarcoma: Effect of Genomic MedicineCamille Tlemsani, Eric Pasmant, Pascaline Boudou-Rouquette, et al.
International Journal of Cancer|November 19, 2025
Fertility preservation in women with sarcoma: A real-world experienceGuillaume Beinse, Pascaline Boudou-Rouquette, Sixtine de Percin, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 27, 2015
Effect of glucuronidation on transport and tissue accumulation of tyrosine kinase inhibitors: consequences for the clinical management of sorafenib and regorafenibCamille Tlemsani, Olivier Huillard, Jennifer Arrondeau, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Bulletin Du Cancer|January 7, 2024
[The French National College of Oncology Teachers (CNEC): Missions, organization, and projects]Florence Huguet, Camille Tlemsani, Jean-Yves Pierga, et al.
STAR Protocols|September 26, 2025
Protocol to set up the CellMinerCDB pharmacogenomics analysis web application with custom cell line dataFathi Elloumi, Camille Tlemsani, Christine M Heske, et al.
Iscience|June 13, 2024
Sarcoma_CellminerCDB: A tool to interrogate the genomic and functional characteristics of a comprehensive collection of sarcoma cell linesCamille Tlemsani, Christine M Heske, Fathi Elloumi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 2016
Acute neurovascular events in cancer patients receiving anti-vascular endothelial growth factor agents: Clinical experience in Paris University HospitalsCamille Tlemsani, Olivier Mir, Dimitri Psimaras, et al.
Clinical Medicine (London, England)|August 3, 2021
Impact of the COVID-19 pandemic on the management of cancer patients: the experience of the cancer outpatients department of a university hospital in ParisCamille Tlemsani, Jennifer Arrondeau, Sixtine De Percin, et al.
Investigational New Drugs|November 1, 2016
Erlotinib pharmacokinetics: a critical parameter influencing acute toxicity in elderly patients over 75 years-oldFrederic Bigot, Pascaline Boudou-Rouquette, Jennifer Arrondeau, et al.
International Journal of Molecular Sciences|January 21, 2023
Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment OptionsCamille Tlemsani, Frédérique Larousserie, Sixtine De Percin, et al.
The American Journal of the Medical Sciences|July 26, 2018
BRCA2 Loss-of-Function and High Sensitivity to Cisplatin-Based Chemotherapy in a Patient With a Pleomorphic Soft Tissue Sarcoma: Effect of Genomic MedicineCamille Tlemsani, Eric Pasmant, Pascaline Boudou-Rouquette, et al.
International Journal of Cancer|November 19, 2025
Fertility preservation in women with sarcoma: A real-world experienceGuillaume Beinse, Pascaline Boudou-Rouquette, Sixtine de Percin, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 27, 2015
Effect of glucuronidation on transport and tissue accumulation of tyrosine kinase inhibitors: consequences for the clinical management of sorafenib and regorafenibCamille Tlemsani, Olivier Huillard, Jennifer Arrondeau, et al.
Pageof 6